Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Phase I/II Study of Bortezomib in Combination with Melphalan and Prednisolone in Japanese Patients with Newly Diagnosed Multiple Myeloma

Kenshi Suzuki, MD, PhD, Kiyoshi Ando, MD, PhD, Akira Sakai, MD, PhD, Shinsuke Iida, MD, PhD, Michinori Ogura, Kensei Tobinai, MD, PhD, Morio Matsumoto, MD, Kosei Matsue, MD, PhD, Yasuhito Terui, MD, PhD, Kazuteru Ohashi, MD, Takaaki Chou, MD, PhD, Kazutaka Sunami, MD, PhD, Atsushi Shinagawa, MD, Nobuyuki Aotsuka, MD, PhD, Hirohiko Shibayama, MD, PhD, Takayuki Takahashi, MD, PhD, Harumi Yamamoto Mukai, MD, PhD, Tomomitsu Hotta, MD, PhD

Blood (2011) 118 (21): 5132.

https://doi.org/10.1182/blood.V118.21.5132.5132

Published: 2011

Journal Articles

Relevance of the Daily Dose of Imatinib Mesylate (IM) Rather Than Its Trough Plasma Concentration for Achieving Deep Molecular Response in Patients with Chronic Myeloid Leukemia.

Chikashi Yoshida, MD, PhD, Takuya Komeno, MD, MPH, PhD, Mitsuo Hori, MD, PhD, Tomofumi Kimura, MD, PhD, Masami Fujii, MD, PhD, Yasushi Okoshi, MD, PhD, Kazumi Suzukawa, MD, PhD, Shigeru Chiba, MD, PhD, Yuichi Hasegawa, MD, PhD, Harumi Yamamoto Mukai, MD, PhD, Takayoshi Ito, MD, PhD, Seiichi Shimizu, MD, PhD, Masaharu Kamoshita, MD, PhD, Daisuke Kudo, MD, Atsushi Shinagawa, MD, PhD, Norio Chikatsu, MD, PhD, Yuriko Monma, MD, Norimichi Watanabe, MD, PhD, Hiroshi Kojima, MD, PhD

Blood (2009) 114 (22): 1112.

https://doi.org/10.1182/blood.V114.22.1112.1112

Published: 2009

Journal Articles

The Critical Function of c-Myb and CD9 On Megakaryopoiesis.

Harumi Yamamoto Mukai, MD, PhD, Tomoko Kouno, Hozumi Motohashi, Yukinori Kozuma, Hiroshi Kojima, MD, PhD, Haruhiko Ninomiya, MD, PhD, Masayuki Yamamoto, MD, PhD

Blood (2009) 114 (22): 4587.

https://doi.org/10.1182/blood.V114.22.4587.4587

Published: 2009

Journal Articles

Post-Marketing Surveillance of Bortezomib Treatment for Multiple Myeloma (MM) in Japan: Results of Interim Analysis by the Velcade Japan Proper Use Guideline Committee

Shinsuke Iida, MD, Harumi Yamamoto Mukai, MD, PhD, Kazuma Ohyashiki, MD, PhD, Kensei Tobinai, MD, PhD, Shin-ichiro Okamoto, MD, PhD, Michinori Ogura, MD, PhD, Takayuki Ishikawa, MD, PhD, Kiyohiko Hatake, MD, PhD, Tomomitsu Hotta, MD

Blood (2008) 112 (11): 5198.

https://doi.org/10.1182/blood.V112.11.5198.5198

Published: 2008

Journal Articles

Transgene Insertion into the Proximity of the c-myb Gene Disrupts Erythroid-Megakaryocytic Lineage Bifurcation.

Harumi Yamamoto Mukai, MD, PhD, Hozumi Motohashi, MD, PhD, Toshiro Nagasawa, MD, PhD, Masayuki Yamamoto, MD, PhD

Blood (2006) 108 (11): 1172.

https://doi.org/10.1182/blood.V108.11.1172.1172

Published: 2006

NARROW

A Phase I/II Study of Bortezomib in Combination with Melphalan and Prednisolone in Japanese Patients with Newly Diagnosed Multiple Myeloma

Relevance of the Daily Dose of Imatinib Mesylate (IM) Rather Than Its Trough Plasma Concentration for Achieving Deep Molecular Response in Patients with Chronic Myeloid Leukemia.

The Critical Function of c-Myb and CD9 On Megakaryopoiesis.

Post-Marketing Surveillance of Bortezomib Treatment for Multiple Myeloma (MM) in Japan: Results of Interim Analysis by the Velcade Japan Proper Use Guideline Committee

Transgene Insertion into the Proximity of the c-myb Gene Disrupts Erythroid-Megakaryocytic Lineage Bifurcation.

Email alerts

ASH Publications

American Society of Hematology

A Phase I/II Study of Bortezomib in Combination with Melphalan and Prednisolone in Japanese Patients with Newly Diagnosed Multiple Myeloma

Relevance of the Daily Dose of Imatinib Mesylate (IM) Rather Than Its Trough Plasma Concentration for Achieving Deep Molecular Response in Patients with Chronic Myeloid Leukemia.

The Critical Function of c-Myb and CD9 On Megakaryopoiesis.

Post-Marketing Surveillance of Bortezomib Treatment for Multiple Myeloma (MM) in Japan: Results of Interim Analysis by the Velcade Japan Proper Use Guideline Committee

Transgene Insertion into the Proximity of the c-myb Gene Disrupts Erythroid-Megakaryocytic Lineage Bifurcation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only